Voermann Karsten
SEC CIK 1822140 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | CFO | 363.6K | — | $2.62M | 32 | 2021-07-28 | 2025-01-08 |
Most active insiders at GDRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRANCISCO PARTNERS IV, L.P. | 10% | — | $9.68M |
| 2 | SEA VII Management, LLC | 10% | — | $95.1K |
| 3 | Fengler Justin | See Remarks | — | — |
| 4 | Chan Thomas (TC) | CAO | — | — |
| 5 | Barnes Wendy Lynn | See Remarks, Dir | — | — |
| 6 | Nabiey Romin | CAO | — | — |
| 7 | Hirsch Douglas Joseph | Dir | — | — |
| 8 | Bezdek Trevor | Dir | — | — |
| 9 | McGinnis Christopher A | See Remarks | — | — |
| 10 | Bruehlman Ronald E | Dir | — | — |
Voermann Karsten made no open-market trades at GDRX in the last 12 months.
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-08 | 2025-01-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $4.41 | -29.0K | 363.6K | -7% | -$128.0K |
| D | 2025-01-08 | 2025-01-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +89.3K | 392.6K | +29% | — |
| D | 2024-12-09 | 2024-12-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $4.91 | -24.7K | 303.3K | -8% | -$121.1K |
| D | 2024-12-09 | 2024-12-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 328.0K | +20% | — |
| D | 2024-09-09 | 2024-09-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $7.71 | -24.7K | 273.9K | -8% | -$190.4K |
| D | 2024-09-09 | 2024-09-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 298.6K | +22% | — |
| D | 2024-06-10 | 2024-06-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $8.55 | -21.5K | 244.5K | -8% | -$183.7K |
| D | 2024-06-10 | 2024-06-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 266.0K | +26% | — |
| D | 2024-03-08 | 2024-03-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 229.2K | +31% | — |
| D | 2024-03-08 | 2024-03-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $7.54 | -17.2K | 212.0K | -8% | -$130.0K |
| D | 2023-12-08 | 2023-12-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | $0.00 | +54.1K | 199.9K | +37% | $0 |
| D | 2023-12-08 | 2023-12-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $5.94 | -24.8K | 175.1K | -12% | -$147.1K |
| D | 2023-09-08 | 2023-09-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 165.6K | +48% | — |
| D | 2023-09-08 | 2023-09-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $6.16 | -19.8K | 145.8K | -12% | -$121.7K |
| D | 2023-06-12 | 2023-06-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $5.41 | -16.6K | 111.5K | -13% | -$89.9K |
| D | 2023-06-12 | 2023-06-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 128.1K | +73% | — |
| D | 2023-03-09 | 2023-03-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 91.5K | +145% | — |
| D | 2023-03-09 | 2023-03-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $5.50 | -17.4K | 74.1K | -19% | -$95.7K |
| D | 2022-12-12 | 2022-12-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | F - Tax | $4.98 | -16.7K | 37.4K | -31% | -$83.0K |
| D | 2022-12-12 | 2022-12-08 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | — | +54.1K | 54.1K | New | — |
| D | 2021-12-30 | 2021-12-28 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | $6.84 | +12.5K | 12.5K | New | +$85.5K |
| D | 2021-12-30 | 2021-12-28 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | S - Sale+OE | $33.05 | -12.5K | 0 | -100% | -$413.1K |
| DM | 2021-12-03 | 2021-12-01 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | S - Sale+OE | $39.43 | -12.5K | 8,311 | -60% | -$492.9K |
| D | 2021-12-03 | 2021-12-01 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | $6.84 | +12.5K | 12.5K | New | +$85.5K |
| D | 2021-11-03 | 2021-11-01 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | $6.84 | +12.5K | 12.5K | New | +$85.5K |
| DM | 2021-11-03 | 2021-11-01 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | S - Sale+OE | $43.34 | -12.5K | 200 | -98% | -$541.7K |
| DM | 2021-09-29 | 2021-09-28 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | S - Sale+OE | $40.31 | -7,500 | 500 | -94% | -$302.3K |
| D | 2021-09-29 | 2021-09-28 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | $6.84 | +7,500 | 7,500 | New | +$51.3K |
| D | 2021-09-01 | 2021-08-30 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | $6.84 | +12.5K | 12.5K | New | +$85.5K |
| DM | 2021-09-01 | 2021-08-30 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | S - Sale+OE | $37.01 | -12.5K | 0 | -100% | -$462.6K |
| D | 2021-07-30 | 2021-07-28 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | M - OptEx | $6.84 | +12.5K | 12.5K | New | +$85.5K |
| DM | 2021-07-30 | 2021-07-28 | GDRX | GoodRx Holdings, Inc. | Voermann Karsten | CFO | S - Sale+OE | $32.75 | -12.5K | 7,842 | -61% | -$409.4K |
Purchase Sale Sale after option exercise All abbreviations